Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 124Precursor Cell Lymphoblastic Leukemia-Lymphoma 76Leukemia 66Myelodysplastic Syndromes 56Lymphoma 34Lymphoma, Non-Hodgkin 33Leukemia, Lymphocytic, Chronic, B-Cell 30Hodgkin Disease 27Leukemia, Myelogenous, Chronic, BCR-ABL Positive 26Burkitt Lymphoma 25Multiple Myeloma 24Lymphoma, Mantle-Cell 19Lymphoma, Follicular 18Hematologic Neoplasms 18Lymphoma, B-Cell, Marginal Zone 17Lymphoma, Large B-Cell, Diffuse 16Leukemia, Biphenotypic, Acute 16Recurrence 15Myeloproliferative Disorders 15Congenital Abnormalities 15Leukemia, Myelomonocytic, Chronic 13Anemia, Refractory, with Excess of Blasts 13Lymphoma, Large-Cell, Immunoblastic 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Blast Crisis 10Graft vs Host Disease 9Neoplasms, Plasma Cell 8Leukemia, Myelomonocytic, Juvenile 8Primary Myelofibrosis 7Leukemia, Myelomonocytic, Acute 7

Interventions

Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4fludarabine phosphate 3Epoetin Alfa 3Darbepoetin alfa 3liposomal amphotericin B 2Whole-Body Irradiation 2Tacrolimus 2Mycophenolic Acid 2Morphine 2Methylprednisolone 2Interferon-alpha 2Filgrastim 2Fentanyl 2Cyclosporine 2Caspofungin 2Carboplatin 2Busulfan 2Bortezomib 2Antilymphocyte Serum 2tanespimycin 1sargramostim 1pyroxamide 1ibrutinib 1ferrous sulfate 1ferric gluconate 1aldesleukin 1Watchful Waiting 1Topotecan 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Monoclonal Gammopathy of Undetermined Significance × Granulocyte Colony-Stimulating Factor × Other hematologic neoplasm × Clear all
NCT00245037 2017-09-27

Bu Flu TBI

OHSU Knight Cancer Institute

Phase 1/2 Completed
147 enrolled 19 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡